Patents by Inventor Stan Bastiras

Stan Bastiras has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PRODUCING A RECOMBINANT PEPTIDE
    Publication number: 20150315259
    Abstract: Methods of producing a recombinant peptide, such as vessel dilator peptide (VSDL), are disclosed, including a particular method involving expressing a fusion polypeptide comprising concatemeric repeats of the peptide wherein the peptide is flanked by peptide cleavage sites, and cleaving the fusion polypeptide at the peptide cleavage sites with a cleaving agent(s) so as to release the peptide from the fusion polypeptide. Expression constructs and host cells for producing the fusion polypeptide and purification methods for the recombinant peptide are also disclosed.
    Type: Application
    Filed: March 19, 2013
    Publication date: November 5, 2015
    Inventors: Stan Bastiras, Angelo Guidolin, Ben Hunt, Muhammad Saif Raisheed, Reza Zareie
  • Interleukin-5 antagonist
    Patent number: 6465616
    Abstract: The present invention relates to modified and variant forms of Interleukin-5 molecules capable of antagonizing or reducing the activity of IL-5 and their use in ameliorating, abating or otherwise reducing the aberrant effects caused by native or mutant forms of IL-5.
    Type: Grant
    Filed: April 12, 1999
    Date of Patent: October 15, 2002
    Assignees: BresaGen Limited, Medvet Science Pty. Ltd.
    Inventors: Angel Lopez, Matthew Vadas, Frances Shannon, Stan Bastiras, Allan William Hey
  • Haemopoietic growth factor antagonists and uses therefor
    Patent number: 6322791
    Abstract: The present invention relates generally to variant recombinant forms of haemopoietic growth factors useful as antagonists to the corresponding native haemopoietic growth factor and their use in ameliorating aberrant effects caused by the native molecules and in the treatment of tumours and cancers and inflammation.
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: November 27, 2001
    Assignee: BreasaGen Limited
    Inventors: Mathew Alexander Vadas, Angel Francisco Lopez, Mary Francis Shannon, Keat-Chye Cheah, Carol Ruth Senn, Stan Bastiras, Allan Robins